Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

global access

New asthma training for nurses

A programme to help provide practice nurses with additional knowledge about the causes and management of asthma has been launched in the UK

Diabetes aspect of QiC announced

The first therapy area covered by the Quality in Care (QiC) Programme, diabetes, launches in September 2010

NICE rejects omalizumab use in children

NICE has rejected the use of omalizumab for the treatment of severe persistent allergic asthma in children aged 6 to 11 years

NHS Reforms – the road ahead

The NHS reform agenda represents a steep learning curve for all concerned as they struggle to come to terms with the changes required to adopt and implement planned changes successfully

Monitoring of controlled drugs improves

A report released by the Care Quality Commission has said the monitoring of controlled drugs has improved, though more professional guidance is needed

Emergency drug fund for cancer patients

The UK government has announced a £50m fund allowing patients access to cancer drugs up to six months earlier than would otherwise be possible

Doctors.net launches commissioning website

Doctors.net.uk has launched a microsite to help prepare doctors in the UK for the new NHS commissioning process

NHS spending on diabetes ‘too high’

Researchers say NHS spending on diabetes treatments is excessive, accounting for 7 per cent of the overall prescribing budget in the UK

UK healthcare public consultations launched

The UK's Department of Health has launched two public consultations requesting views on the government's plans for NHS reform

QIPP event looks at joint working

A recent QIPP Challenge event found that the NHS and the pharmaceutical industry are keen to develop the possibilities of joint working

NHS overhaul plans unveiled

Health Secretary Andrew Lansley has unveiled a proposal to radically shake up the NHS that aims to cut costs by £20bn by 2014

Civitas says NHS shake up could be costly

Think-tank, the Institute for the Study of Civil Society (Civitas), predicts that the government's health plans could set the NHS back up to three years

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links